Tumour necrosis factor-alpha expression in segmental colitis associated with diverticulosis is related to the severity of the endoscopic damage

被引:10
作者
Tursi, Antonio [1 ]
Elisei, Walter [2 ]
Brandimarte, Giovanni [3 ]
Giorgetti, Gian Marco [4 ]
Inchingolo, Cosimo Damiano [5 ]
Nenna, Rosanna [5 ]
Ierardi, Enzo [6 ]
机构
[1] ASL BAT, Serv Gastroenterol Terr, Andria, Italy
[2] ASL Roma H Albano Laziale, UOC Gastroenterol, Rome, Italy
[3] Osped Cristo Re, UOS Gastroenterol, Rome, Italy
[4] Osped S Eugenio, UOD Endoscopia Digest & Nutr, Rome, Italy
[5] ASL BAT, Osped Lorenzo Bonomo, UOC Anat & Istol Patol, Andria, Italy
[6] Univ Foggia, Sez Gastroenterol, Dipartimento Sci Med, Foggia, Italy
关键词
Endoscopy; Segmental colitis associated with diverticulosis; Tumoural necrosis factor alpha; ULCERATIVE-COLITIS; MAINTENANCE THERAPY; DOWN-REGULATION; CROHNS-DISEASE; INFLIXIMAB; INFLAMMATION; CYTOKINES; SPECTRUM; MARKER; CELLS;
D O I
10.1016/j.dld.2010.11.014
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Tumour necrosis factor-alpha expression may be increased in segmental colitis associated with diverticulosis. Aims: To assess tumour necrosis factor-alpha expression in segmental colitis associated with diverticulosis in relation with the severity of the endoscopic damage. Methods: 21 patients affected by segmental colitis associated with diverticulosis were studied (15 M, 6 F, mean age 58.87 years, range 43-85 years). Segmental colitis associated with diverticulosis was graduated as mild-moderate (patterns A and C) and severe (patterns B and D). Ten patients with moderate-to-severe ulcerative colitis, 10 patients with moderate-to-severe Crohn's disease, and 10 patients with irritable bowel syndrome served as control groups. Results: Tumour necrosis factor-alpha expression was significantly higher in segmental colitis associated with diverticulosis B (42.7%) and segmental colitis associated with diverticulosis D (40%) than in segmental colitis associated with diverticulosis A (19.1%) and segmental colitis associated with diverticulosis C (21.1%).Tumour necrosis factor-alpha expression was lower in segmental colitis associated with diverticulosis A and C than in ulcerative colitis and Crohn's disease, whilst no different tumour necrosis factor-alpha expression was found between segmental colitis associated with diverticulosis B and D and both ulcerative colitis and Crohn's disease.Finally, tumour necrosis factor-alpha expression was significantly lower in irritable bowel syndrome (8%+/- 4) than in every type of segmental colitis associated with diverticulosis. Conclusions: Tumour necrosis factor-alpha expression in segmental colitis associated with diverticulosis seems to be related to the severity of the endoscopic damage. This behaviour, similar to that of the inflammatory bowel diseases (IBD), confirms that this disease should be considered as a subtype of IBD. (C) 2010 Editrice Gastroenterologica ltaliana S.r.l. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:374 / 379
页数:6
相关论文
共 50 条
[21]   Weight gain and tumour necrosis factor-alpha inhibitors in patients with psoriasis [J].
Tan, Eugene ;
Baker, Christopher ;
Foley, Peter .
AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2013, 54 (04) :259-263
[22]   Systematic review with network meta-analysis: the efficacy of anti-tumour necrosis factor-alpha agents for the treatment of ulcerative colitis [J].
Stidham, R. W. ;
Lee, T. C. H. ;
Higgins, P. D. R. ;
Deshpande, A. R. ;
Sussman, D. A. ;
Singal, A. G. ;
Elmunzer, B. J. ;
Saini, S. D. ;
Vijan, S. ;
Waljee, A. K. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (07) :660-671
[23]   Augmented expression of tumour necrosis factor-alpha and lymphotoxin in mononuclear cells in multiple sclerosis and optic neuritis [J].
Navikas, V ;
He, B ;
Link, J ;
Haglund, M ;
Soderstrom, M ;
Fredrikson, S ;
Ljungdahl, A ;
Hojeberg, B ;
Qiao, J ;
Olsson, T ;
Link, H .
BRAIN, 1996, 119 :213-223
[24]   Activation and promotion of adipose stem cells by tumour necrosis factor-alpha preconditioning for bone regeneration [J].
Lu, Zufu ;
Wang, Guocheng ;
Dunstan, Colin R. ;
Chen, Yongjun ;
Lu, William Yenn-Ru ;
Davies, Ben ;
Zreiqat, Hala .
JOURNAL OF CELLULAR PHYSIOLOGY, 2013, 228 (08) :1737-1744
[25]   Maternal and foetal adverse events with tumour necrosis factor-alpha inhibitors in inflammatory bowel disease [J].
Deepak, P. ;
Stobaugh, D. J. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 40 (09) :1035-1043
[26]   Salivary levels of Tumour Necrosis Factor-alpha in patients with recurrent aphthous stomatitis [J].
Eguia-del Valle, Asier ;
Martinez-Conde-Llamosas, Rafael ;
Lopez-Vicente, Jose ;
Uribarri-Etxebarria, Agurne ;
Aguirre-Urizar, Jose-Manuel .
MEDICINA ORAL PATOLOGIA ORAL Y CIRUGIA BUCAL, 2011, 16 (01) :E33-E36
[27]   Ineffectiveness of tumour necrosis factor-alpha inhibition in association with bisphosphonates for the treatment of cherubism [J].
Pagnini, T. ;
Simonini, C. ;
Mortilla, M. ;
Giani, T. ;
Pascoli, L. ;
Cimaz, R. .
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (01) :147-147
[28]   Tumour necrosis factor-alpha (TNF-alpha): The good, the bad and potentially very effective [J].
Barbara, JAJ ;
VanOstade, X ;
Lopez, AF .
IMMUNOLOGY AND CELL BIOLOGY, 1996, 74 (05) :434-443
[29]   Tumour Necrosis Factor-alpha and Nuclear Factor-kappa B Gene Variants in Sepsis [J].
Acar, Leyla ;
Atalan, Nazan ;
Karagedik, E. Hande ;
Ergen, Arzu .
BALKAN MEDICAL JOURNAL, 2018, 35 (01) :30-35
[30]   Risk of serious bacterial infection associated with tumour necrosis factor-alpha inhibitors in children with juvenile idiopathic arthritis [J].
Lee, Wan-Ju ;
Lee, Todd A. ;
Suda, Katie J. ;
Calip, Gregory S. ;
Briars, Leslie ;
Schumock, Glen T. .
RHEUMATOLOGY, 2018, 57 (02) :273-282